Discussion: Moderators: F. Peetoom, C.Th. Smit Sibinga

  • C. Th. Smit Sibinga
  • P. C. Das
  • S. Seidl
Part of the Developments in Hematology and Immunology book series (DIHI, volume 13)

Abstract

Dr. Bussel, I have two questions related to the data you presented on the usage of intravenous immunoglobulins for immune-deficiency patients. You mentioned that although the number of infections decreased, the number of hospital days increased. I would like to know if there was a specific reason for that discrepancy.

Keywords

Pneumonia Heparin Fractionation Thrombocytopenia Gelatin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Martinus Nijhoff Publishing, Boston 1985

Authors and Affiliations

  • C. Th. Smit Sibinga
    • 1
  • P. C. Das
    • 1
  • S. Seidl
    • 2
  1. 1.Red Cross Blood Bank Groningen-DrentheGroningenThe Netherlands
  2. 2.Red Cross Blood Transfusion Service HessenFrankfurt am MainGermany

Personalised recommendations